Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

被引：0
|
作者：
Da Hyun Kang
Sung Soo Jung
Min-Kyung Yeo
Da Hye Lee
Geon Yoo
Sang Yeon Cho
In-Jae Oh
Ju-Ock Kim
Hee Sun Park
Chaeuk Chung
Jeong Eun Lee
机构：
[1] College of Medicine,Division of Pulmonology, Department of Internal Medicine
[2] Chungnam National University,Department of Pathology, College of Medicine
[3] Chungnam National University,Department of Internal Medicine
[4] Korea Institute of Toxicology,undefined
[5] Chungnam National University School of Medicine,undefined
[6] Chonnam National University Medical School,undefined
来源：
BMC Cancer | / 20卷
关键词：
Mig-6; EGFR-TKI; Lung adenocarcinoma; Chemotherapy resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    CANCER SCIENCE, 2018, 109 : 1101 - 1101
  • [43] Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
    Cheong, Hio Teng
    Xu, Fei
    Choy, Chi Tung
    Hui, Connie Wun Chun
    Mok, Tony Shu Kam
    Wong, Chi Hang
    ONCOLOGY LETTERS, 2018, 15 (01) : 901 - 907
  • [44] The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
    Chung, Fu-Tsai
    Ho, Ming-Yun
    Fang, Yueh-Fu
    Hshieh, Meng-Heng
    Wang, Tsai-Yu
    Kuo, Chih-Hsi
    Chen, Hao-Cheng
    Wang, Chun-Hwa
    Lin, Shu-Min
    Yu, Chih-Teng
    Lin, Horng-Chyuan
    Kuo, Han-Pin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Yamada, Tomonori
    Hashimoto, Takafumi
    Takumi, Yohei
    Kobayashi, Ryoji
    Suehiro, Shuji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    CANCER RESEARCH, 2017, 77
  • [46] EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice
    Higo, Hisao
    Ohashi, Kadoaki
    Makimoto, Go
    Nishii, Kazuya
    Kudo, Kenichiro
    Kayatani, Hiroe
    Watanabe, Hiromi
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    LUNG CANCER, 2019, 136 : 86 - 93
  • [47] Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S
    Osoegawa, A.
    Hashimoto, T.
    Takumi, Y.
    Kobayashi, R.
    Miyawaki, M.
    Takeuchi, H.
    Okamoto, T.
    Sugio, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2251 - S2251
  • [48] Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
    Ahn, Hyein
    Kwon, Hyun Jung
    Park, Eunhyang
    Kim, Hyojin
    Chung, Jin-Haeng
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (02) : 130 - 132
  • [49] Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects
    Wada, Koji
    Lee, Jen-Yi
    Hung, Hsin-Yi
    Shi, Qian
    Lin, Li
    Zhao, Yu
    Goto, Masuo
    Yang, Pan-Chyr
    Kuo, Sheng-Chu
    Chen, Hui-Wen
    Lee, Kuo-Hsiung
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (07) : 1507 - 1514
  • [50] Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer
    Liang, Xing-mei
    Qin, Qiong
    Liu, Bo-ning
    Li, Xiao-qing
    Zeng, Li-li
    Wang, Jing
    Kong, Ling-ping
    Zhong, Dian-sheng
    Sun, Lin-lin
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (04): : 648 - 654
12345